Subscribe to our Newsletters !!

    Kumar Jeetendra

    China endorses third COVID-19 antibody for clinical trials

    China has affirmed its third coronavirus immunization for the second period of clinical preliminaries as it detailed 12 new COVID-19 cases, taking the absolute number of contaminations in the nation to 82,816. China has endorsed three coronavirus immunizations, including the one created by Chinese military, the People’s Liberation Army (PLA) for clinical preliminaries. An “inactivated”

    UV Vis Spectroscopy and Recent Changes in Pharmacopeia

    Pharmacopeias provide general chapters describing the apparatus (aka instruments) needed in order to perform the analysis of the drugs described in the monographs. They also describe the procedures to ensure that the instruments perform according to the required criteria. European Pharmacopeia (Ph. Eur.) and the United States Pharmacopeia (USP) are most followed guidelines for regulatory

    ICMR approves the COVID-19 detection kit created at IIT Delhi

    The Indian Institute of Technology (IIT), Delhi has built up a COVID-19 test unit, which has the endorsement of Indian Council of Medical Research (ICMR). “We began chipping away at it before the finish of January and prepared it in a quarter of a year. We needed to add to moderate minimal effort diagnostics that

    Eppendorf AG Reports a Successful Financial Year 2019

    For the Eppendorf Group, an all inclusive dynamic life science organization, 2019 end up being an awesome financial year. Solidified income rose to €803.9 million (earlier year: €729.2 million), relating to an income increment from working business of 10.2% contrasted and a similar period a year ago. Natural development estimated in neighborhood monetary forms totalled

    Which human body Cells are Most Vulnerable to Coronavirus ?

    CAMBRIDGE, MA — Researchers at MIT; the Ragon Institute of MGH, MIT, and Harvard; and the Broad Institute of MIT and Harvard; alongside associates from around the globe have distinguished explicit sorts of cells that give off an impression of being focuses of the coronavirus that is causing the COVID-19 pandemic. Utilizing existing information on

    Serum Institute of India to begin Oxford’s COVID-19 vaccine manufacturing soon

    Significant vaccines producer Serum Institute of India on Sunday said that it was intending to initiate the creation of the immunization created by Oxford University. According to reports, the organization is additionally wanting to dispatch the COVID-19 immunization in the market by October if human preliminaries are directed effectively. Serum Institute of India has joined

    New therapeutic system for tumors like Non-Hodgkin lymphoma: Immunotherapy

    Today, immunotherapy is one of the most encouraging treatment for malignant growth patients. In contrast to radio-or chemo-treatments, immunotherapy intends to “switch on” the patient’s own resistant framework to assault and wipe out the tumor. In any case, tumors, including NHL, frequently change to make themselves undetectable to the invulnerable framework or even adventure cooperations

    First new oral polio vaccine in quite a while

    Stage 1 preliminary shows guarantee for fruition of slowed down annihilation exertion; offers exercises for COVID-19 immunization improvement Before being stopped because of the COVID-19 pandemic, a constant immunization crusade had almost prevailing with regards to annihilating polio from the world. Somewhere in the range of 2000 and 2017, the World Health Organization (WHO) assessed

    ARTES Biotechnology entered in development of SARS-CoV-2 vaccine

    ARTES Biotechnology, the German-based biotech organization gaining practical experience in process improvement for recombinant immunizations, entered advancement of SARS-CoV-2 antibody applicants dependent on its infection like molecule (VLP) based stage advances METAVAX® and SplitCore. METAVAX® is the organization’s foundation for the improvement of immunizations based on wrapped infection like molecule nanostructures (eVLPs) in light of

    Lincoln Pharma gets Gujarat food and drug controller gesture to make HCQ tablets

    Lincoln Pharmaceuticals hit an upper circuit breaking point of 5% at Rs 152.70 after the organization said it got endorsement to fabricate Hydroxychloroquine and Hydroxychloroquine Sulfate tablets to battle Covid-19. Lincoln Pharmaceuticals reported during exchanging hours today, 27 April 2020, that it has gotten endorsement to make Hydroxychloroquine (HCQ) among other basic medications to battle